ANDREW CHIDA: Open Payments
NPI 1043839061 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 14 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $212 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $51 |
| Exact Sciences Corporation | 2 | $33 |
| Novo Nordisk Inc | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: JARDIANCE, Cologuard Collection Kit, ELIQUIS, Kerendia, VYNDAMAX, OPSUMIT, Rybelsus, EVENITY.
Industry payments across NE — which companies pay providers there.
